Karen Akinsanya

Karen Akinsanya is a Director at Nautilus Biotechnology. Karen has also worked as an Associate Vice President, Early Scientific Assessment Lead at Merck Research Labs BD&L group and as a Senior Scientist and Director - Molecular Cellular Biology at Ferring Pharmaceuticals.

Karen Akinsanya has a Doctor of Philosophy (Ph.D.) in Endocrine Physiology from Imperial College London, a BSc in Biochemistry from Queen Mary University of London, and is a Postdoctoral Fellow in Developmental Genetics at UCL. Karen has also completed Executive Education in Managing Teams for Innovation and Success at the Stanford University Graduate School of Business, and Postgraduate Training in Clinical Pharmacology, Drug Development and Regulation at Tufts University.